Investor Relations

Conversion Labs is a rapidly growing direct to consumer telemedicine and wellness company. In addition to our proven online marketing expertise, we have built a technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications directly to patients in all 50 states. We believe telemedicine will transform the American healthcare system by increasing access to care and improving outcomes. We’re proud to be a leader in this rapidly evolving space.

Latest News

{{ `${news.title}` }}

{{ news.description }}

Read More {{ news.pubDate }}

Receive automated Investor Alerts directly to your inbox

SEC Filings

{{ `${}.) ${sec.title}` }}

{{ sec.description }}

Investor Contact Information


Conversion Labs, Inc.
800 Third Avenue
Suite 2800
New York, NY 10022
Toll-Free: (866) 351-5907

Investor Relations

Conversion Labs Investor & Media Relations Contact:
Ron Both, CMA
Email Contact
T: 949-432-7566

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601